How do you use a Utibron Neohaler?
- Utibron Neohaler is given as an oral inhalation (breathed in through your mouth from a special device). Utibron Neohaler from Sunovion was discontinued from the U.S. market in March of 2020, but inhalers may be still be available at the pharmacy. A generic option is not commercially available.
- One capsule, which is placed in the device, comes in the package with the Utibron Neohaler. The capsule is NOT to be swallowed. The capsule is placed inside the device prior to inhaling the medicine. Also, do not place the capsule in the mouthpiece of the Neohaler Neohaler. The capsules come in a blister pack.
- Use one Utibron capsule inhaled through the Utibron Inhaler two times each day (one capsule in the morning and one capsule in the evening) for the treatment of chronic obstructive pulmonary disease (COPD). Do not use two capsules at one time, and do not use more than 2 capsules in a day.
- Follow the dosing instructions given to you by your healthcare provider. Ask your health care provider to teach you how to use the device.
Specific instructions and diagrams on how to use the Utibron Neohaler are also found in the patient information under "Instructions for Use".
How does Utibron work in COPD?
Utibron Neohaler contains two medicines: indacaterol maleate and glycopyrrolate. Glycopyrrolate is an anticholinergic, and indacaterol is a long-acting beta-agonist (LABA) bronchodilator. LABA and anticholinergic medicines help the muscles around the airways in your lungs stay relaxed. This helps to prevent COPD symptoms such as wheezing, coughing, chest tightness, and shortness of breath. This medication is NOT used to treat asthma.
Utibron is used in adult patients 18 years and older for COPD. COPD is a chronic lung disease that includes chronic bronchitis, emphysema, or both.
Utibron Neohaler is not used to treat sudden breathing problems due to COPD. Use a short-acting beta2-agonist medicine (a rescue inhaler such as albuterol) to treat sudden breathing symptoms of COPD. If you do not have a rescue inhaler, contact your healthcare provider to have one prescribed for you. Always keep your rescue inhaler with you.
This is not all the information you need to know about Utibron (indacaterol maleate and glycopyrrolate) Neohaler for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full Utibron Neohaler information here, and discuss this information and any questions you have with your doctor or other health care provider.
- FDA lists Arcapta, Seebri, and Utibron Neohalers as discontinued (updated). OINDP News. March 12, 2020. Accessed March 2, 2021 at https://www.oindpnews.com/2020/03/fda-lists-arcapta-seebri-and-utibron-neohalers-as-discontinued/#
- Utibron Neohaler (indacaterol maleate and glycopyrrolate). [product information]. Revised 5/2019. FDA. Accessed March 2, 2021 at https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207930s004lbl.pdf
Related medical questions
- What is the normal oxygen level for someone with COPD?
- What is the life expectancy of someone with COPD?
- Is Symbicort a steroid inhaler?
- What foods should be avoided with COPD?
- What are the 4 stages of COPD?
- Can severe asthma lead to COPD?
- Prednisone: What are 12 Things You Should Know?
- Why do you not give oxygen to COPD patients?
- Can vitamin C prevent or treat COVID-19 (coronavirus)?
- What is Fluimucil used for?
- What is the difference between emphysema and COPD?